Vifor Pharma and Angion sign license agreement for ANG-3777 in nephrology indications Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777 ANG-3777 is a first in class small-molecule hepatocyte growth factor (HGF) mimetic, addressing a significant unmet need for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury Angion will receive up to USD 80 million, which includes 30 million upfront payment, 30 million equity investment and 20 million clinical study milestone payments with further milestone payments and tiered royalties on global sales - Vifor Pharma will host conference call and webcast today at 2:00 pm CET - St Gallen and Uniondale, NY, November 09, 2020 Vifor Pharma and Angion Biomedica Corp. (Angion) announced the signing of a licensing agreement for the commercialization of ANG-3777, currently developed for treatment of delayed graft function (DGF) and cardiac surgery-associated acute kidney injury (CSA-AKI). ANG-3777 was engineered to mimic the biological activity of HGF, activating critical pathways in the bodys natural organ repair process following an acute organ injury. Continue reading →

Cardiac Surgery Instruments Market Report The research study on the Global Cardiac Surgery Instruments Market is a thorough investigation of the value and supply chain of the market and offers all-inclusive data about the industry. Continue reading →

"One of the greatest gifts is to feel alive while you are alive," Katherine Standefer says. Continue reading →

"Over the course of my career, putting patients at the center of everything I do has been my guiding principle," said Dr. Cosgrove Continue reading →

By Express News Service CHENNAI: The Kauvery Hospital has performed three complex aortic dissection surgeries within a month. A statement from the hospital said aortic dissection means a tear in the aorta, the largest blood vessel that carries blood from heart to the other parts of the body Continue reading →

Informative Report On Cardiovascular Surgical Devices and Technologies Market 2020 Cardiovascular Surgical Devices and Technologiesmarket has recently added by Grand View Reportto its massive repository. It offers the continual advancements in technologies which helps to understand the platform for the development of the businesses. It offers numerous strategies for boosting the performance of the companies. Continue reading →

This article was originally published here Heart Lung Circ. 2020 Nov 3:S1443-9506(20)31414-1. doi: 10.1016/j.hlc.2020.09.928. Continue reading →

Five common therapies and practices related to children's heart health may be unnecessary, and physicians and parents should be careful about using them, the American Academy of Pediatrics (AAP) explains in guidance released this week. Continue reading →

This article was originally published here J Saudi Heart Assoc. 2020 May 10;32(2):127-133. Continue reading →

KING OF PRUSSIA, Pa., Nov. 5, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the study design manuscript for its landmark AEGIS-II (ApoA-I Event reducinG in Ischemic Syndromes II) has been published in the American Heart Journal. Continue reading →